Anaerobic Infections

New England Journal of Medicine

Volumn 290, Issue 23, 1974, Pages 1289-1294

  Gorbach, Sherwood L ^a   Bartlett, John G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

AEROBIC METABOLISM; ANAEROBIC GROWTH; ANIMAL; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BACTERIUM; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PATHOGENICITY; REVIEW; SEPTICEMIA; THROMBOEMBOLISM; WOUND INFECTION;

AEROBIOSIS; ANAEROBIOSIS; ANIMAL; ANTIBIOTICS; BACTERIA; BACTERIAL INFECTIONS; BACTERIOLOGICAL TECHNIQUES; DRUG RESISTANCE, MICROBIAL; HUMAN; MICROBIAL SENSITIVITY TESTS; SEPTICEMIA; THROMBOEMBOLISM; WOUND INFECTION;

EID: 0016385815     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197406062902305     Document Type: Review

References (37)

1. Mergenhagen SE, Thonard JC, Scherp HW: Studies on synergistic infections. I. Experimental infections with anaerobic streptococci. J Infect Dis 103: 33–44, 1958
2. Roberts DS: Synergistic mechanisms in certain mixed infections. J Infect Dis 120: 720–724, 1969
3. Fildes P: Tetanus. IX. The oxidation-reduction potential of the subcutaneous tissue fluid of the guinea-pig: its effect on infection. Br J Exp Pathol 10: 197–204, 1929
4. Woods DD, Foster MA: Metabolic considerations relating to the life of bacteria in vivo, Microbial Behavior “In Vivo” and “In Vitro ” Fourteenth Symposium of the Society for General Microbiology. Edited by H Smith. J Tavlor. London, Cambridge University Press, 1964. pp 30–43
5. Gesner BM, Jenkin CR: Production of heparinase by bacteroides. J Bacteriol 81: 595–604, 1961
6. Altemeier WA, Hill EO, Fullen WD: Acute and recurrent thromboembolic disease: new concept of etiology. Ann Surg 170: 547–558, 1969
7. Bjornson HS, Hill EO: Bacteroidaceae in thromboembolic disease: effects of cell wall components on blood coagulation in vivo and in vitro. Infect Immun 8: 911–918, 1973
8. Loesche WJ: Oxygen sensitivity by various anaerobic bacteria. Appl Microbiol 18: 723–727, 1969
9. Attebery HR, Sutter VL, Finegold SM: Normal human intestinal flora, Proceedings of the International Conference on Anaerobic Bacteria, November 27–29, 1972. Atlanta, Georgia, Center for Disease Control (in press)
10. Hanke ME, Katz YJ: An electrolytic method for controlling oxidation-reduction potential and its application in the study of anaerobiosis. Arch Biochem Biophys 2: 183–200, 1943
11. Bornstein DL, Weinberg AN, Swartz AN, Swartz MN, et al: Anaerobic infections — review of current experience. Medicine (Baltimore) 43: 207–232, 1964
12. Committee on Trauma of the National Research Council. Postoperative wound infection. Ann Surg 160: Suppl: 82–113, 1964
13. Davis CE, Hunter WJ, Ryan JL, et al: Simple method for culturing anaerobes. Appl Microbiol 25: 216–221, 1973
14. Martin WJ: Practical method for isolation of anaerobic bacteria in the clinical laboratory. Appl Microbiol 22: 1168–1171, 1971
15. Spaulding EH, Vargo V, Michaelson TC, et al: A comparison of two procedures for isolating anaerobic bacteria from clinical specimens, Proceedings of the International Conference on Anaerobic Bacteria, November 27–29, 1972. Atlanta, Georgia, Center for Disease Control (in press)
16. Zabransky RJ: Isolation of anaerobic bacteria from clinical specimens. Mayo Clin Proc 45: 256–264, 1970
17. Quick JD, Goldeberg HS, Sonnenwirth Achéal: Human antibody to Bacteroidaceae. Am J Clin Nutr 25: 1351–1356, 1972
18. Griffin MH: Fluorescent antibody techniques in the identification of the gram-negative nonsporeforming anaerobes. Health Lab Sci 7: 78–83, 1970
19. Gorbach SL, Mayhew JW, Bartlett JG, et al: Rapid diagnosis of Bacteroides fragilis infections by direct gas-liquid chromatography of clinical specimens. Clin Res 22: 442a, 1974
20. Martin WJ, Gardner M, Washington JA II: In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens. Antimicrob Agents Chemother 1: 148–158, 1972
21. Finegold SM, Posnick DJ, Miller LG, et al: Sensitivity of major Bacteroides groups to antibacterial agents. Bacteriol Proc p 64, 1965
22. Finegold SM, Sugihara PT, Miller AB: Susceptibility of anaerobic cocci to antibacterial agents. Bacteriol Proc p 96, 1967
23. Bartlett JG, Sutter VL, Finegold SM: Treatment of anaerobic infections with lincomycin and clindamycin. N Engl J Med 287: 1006–1010, 1972
24. DeHaan RM, Pfeifer, Schellenberg D: In vitro susceptibility of anaerobic isolates with reference to selection of therapeutic agents, Infectious Disease Reviews. Third edition. Edited by WJ Holloway. Mt. Kisco, New York, Futura Publishing Company (in press)
25. Romig DA, et al: Intravenous clindamycin therapy for bacterial endocarditis. Presented at the 13th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, September 19–21, 1973
26. Del Bene VE, Farrar WE Jr: Cephalosporinase activity in Bacteroides fragilis. Antimicrob Agents Chemother 3: 369–372, 1973
27. Tally FP, Sutter VL, Finegold SM: Metronidazole versus anaerobes: in vitro data and initial clinical observations. Calif Med 117(6):22–26, 1972
28. Haldane EV, van Rooyen CE: Treatment of severe bacteroides infections with parenteral clindamycin. Can Med Assoc J 107: 1177–1181, 1972
29. Fass RJ, Scholand FJ, Hodges GR, et al: Clindamycin in the treatment of serious anaerobic infections. Ann Intern Med 78: 853–859, 1973
30. Douglas RL, Kislak JW: Treatment of Bacteroides fragilis bacteremia with clindamycin. J Infect Dis 128: 569–571, 1973
31. Chow AW, Montgomerie JC, Guze LB: Parenteral clindamycin phosphate for severe anaerobic infection: clinical and laboratory evaluation. Arch Intern Med (in press)
32. Cohen LE, McNeill CJ, Wells RF: Clindamycin-associated colitis. JAMA 223: 1379–1380, 1973
33. Reiner L, Schlesinger MJ, Miller GM: Pseudomembranous colitis following aureomycin and chloramphenicol. Arch Pathol 54: 39–67, 1952
34. Thadepalli H, Gorbach S, Bartlett J: Apparent failure of chloramphenicol in anaerobic infections. Presented at the 13th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, September 17–21, 1973
35. Weiss W: Cavity behavior in acute, primary, nonspecific lung abscess. Am Rev Resp Dis 108: 1273–1275, 1973
36. Gorbach SL, Thadepalli H: Clindamycin in pure and mixed anaerobic infections. Arch Intern Med (in press)
37. Leigh DA: Bacteroides infections. Lancet 2: 1081–1082, 1973